Comparison of the Therapeutic Effect of Acupressure Therapy and Iberogast ® (STW-5) in Children With Functional Nausea
Status:
Completed
Trial end date:
2020-09-16
Target enrollment:
Participant gender:
Summary
Functional gastrointestinal disorders are common disorders that are characterized by
persistent and recurring GI symptoms. These occur as a result of abnormal functioning of the
GI tract and are not caused by structural or biochemical abnormalities. As a result, medical
tests- such as blood tests and endoscopic exams- have essentially normal/negative
(non-disease) results. More than 20 functional GI disorders have been identified. They can
affect any part of the GI tract. One of the most common functional disorders is nausea and
dyspepsia (pain or discomfort in the upper abdominal area, feeling of fullness, bloating).
Any chronic illness, including functional nausea, will affect a person's health-related
quality of life (general well-being, ability to carry out everyday activities), additional
psychosocial disturbances and amplify the experienced illness.
The majority of children suffering from functional nausea in Europe are treated with
Iberogast®. a herbal mixture, whose effect was demonstrated in several studies. Since
Iberogast® is not available in the United States of America, children there receive an
acupressure therapy. The American gastroenterologists refer hereby to several studies, which
have shown, that the positive effect of such therapies in patients with chemotherapy-induced
nausea is even greater than a therapy with ondansetron. Since acupressure is able to reduce
somatic nausea, it is also believed to decrease functional nausea, but it has never been
investigated. Therefore, there are no data. That's why Investigators want to compare the
efficacy of these two therapies, that is, Iberogast® and acupressure